This web site is part of the Business Intelligence Division of Informa PLC
This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.
Drug Names(s): AAE581
Description: AAE581 is an orally available inhibitor of cathepsin K. Cathepsin K is a enzyme that degrades bone matrix (collagen). AAE581 inhibits cathepsin K in osteoclasts, leading to reduced collagen breakdown and decreased bone resorption.
Pink Sheet Weekly Trademark Review Sept. 30, 2014
Pink Sheet Bar Code Rule Clears OMB
Additional information available to subscribers only: